Cart
sales@molnova.com
ML-211
CAS No. 2205032-89-7
ML-211( —— )
Catalog No. M23993 CAS No. 2205032-89-7
ML-211 is a carbamate-based dual inhibitor of LYPLA1 (IC50?= 17 nM) and the related LYPLA2 (IC50?= 30 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 272 | In Stock |
|
| 10MG | 408 | In Stock |
|
| 25MG | 672 | In Stock |
|
| 50MG | 945 | In Stock |
|
| 100MG | 1278 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameML-211
-
NoteResearch use only, not for human use.
-
Brief DescriptionML-211 is a carbamate-based dual inhibitor of LYPLA1 (IC50?= 17 nM) and the related LYPLA2 (IC50?= 30 nM).
-
DescriptionML-211 is a carbamate-based dual inhibitor of LYPLA1 (IC50?= 17 nM) and the related LYPLA2 (IC50?= 30 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorLYPLA1|LYPLA2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2205032-89-7
-
Formula Weight418.5
-
Molecular FormulaC25H30N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCC(C)(C)C1CCN(CC1)C(=O)N2N=CC(=N2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Adibekian A , Martin B R , Chang J W , et al. Characterization of a Selective, Reversible Inhibitor of Lysophospholipase 2 (LYPLA2)[J]. National Center for Biotechnology Information (US), 2010.
molnova catalog
related products
-
Ginsenoside F4
Ginsenoside F4 has inhibitory effect on human lymphocytoma JK cell by inducing its apoptosis, the mechanism is related to the mitochondrial dysfunction and the increase of Bax expression and decrease of Bcl-2 expression.
-
3-Geranyl-3-prenyl-2...
3'-Geranyl-3-prenyl-2',4',5,7-tetrahydroxyflavone is a natural product from Morus alba.
-
7Beta-Hydroxycholest...
7beta-Hydroxycholesterol, a major cytotoxin in oxidized LDL, induces Ca(2+) oscillations, MAP kinase activation and apoptosis in human aortic smooth muscle cells.
